Results 131 to 140 of about 7,380 (205)

Therapeutic Efficacy and Effects of Artemether-Lumefantrine and Artesunate-Amodiaquine Coformulated or Copackaged on Malaria-Associated Anemia in Children with Uncomplicated Plasmodium falciparum Malaria in Southwest Nigeria [PDF]

, 2011
Grace O. Gbotosho, Akintunde Sowunmi, Titilope M. Okuboyejo, Christian T. Happi, Onikepe A. Folarin, OS Michael, Elsie O. Adewoye   +6 more
openalex   +1 more source

Comparing changes in haematologic parameters occurring in patients included in randomized controlled trials of artesunate-amodiaquine vs single and combination treatments of uncomplicated falciparum in sub-Saharan Africa [PDF]

, 2012
Julien Zwang, Jean Louis Ndiaye, Abdoulaye Djimdé, Grant Dorsey, Andreas Mårtensson, Corine Karema, Piero Olliaro   +6 more
openalex   +1 more source

Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance. [PDF]

Lancet Infect Dis
Ishengoma DS, Mandara CI, Bakari C, Fola AA, Madebe RA, Seth MD, Francis F, Buguzi CC, Moshi R, Garimo I, Lazaro S, Lusasi A, Aaron S, Chacky F, Mohamed A, Njau RJA, Kitau J, Rasmussen C, Bailey JA, Juliano JJ, Warsame M.   +20 more
europepmc   +1 more source

The efficacy and tolerability of artemisinin-piperaquine (Artequick®) versus artesunate-amodiaquine (Coarsucam™) for the treatment of uncomplicated Plasmodium falciparum malaria in south-central Vietnam [PDF]

, 2012
Nguyễn Xuân Thành, Trieu Nguyen Trung, Nguyen Chinh Phong, Huynh Hong Quang, Bui Dai, G. Dennis Shanks, Marina Chavchich, Michael D. Edstein   +7 more
openalex   +1 more source

A furoxan–amodiaquine hybrid as a potential therapeutic for three parasitic diseases [PDF]

, 2012
Bryan T. Mott, Ken Cheng, Rajarshi Guha, Valerie P. Kommer, David L. Williams, Jon J. Vermeire, Michael Cappello, David J. Maloney, Ganesha Rai, Ajit Jadhav, Anton Simeonov, James Inglese, Gary H. Posner, Craig J. Thomas   +13 more
openalex   +1 more source

Plasmodium falciparum transcription factor AP2-06B is mutated at high frequency in Southeast Asia but does not associate with drug resistance. [PDF]

Front Cell Infect Microbiol
Shi Q, Wang C, Yang W, Ma X, Tang J, Zhang J, Zhu G, Wang Y, Liu Y, He X.   +9 more
europepmc   +1 more source

Parasite clearance and protection from Plasmodium falciparum infection (PCPI): a three-arm, parallel, double-blinded, placebo-controlled, randomised trial of presumptive sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine plus amodiaquine versus artesunate monotherapy among asymptomatic children 3-5 years of age in Cameroon. [PDF]

BMC Infect Dis
Martinez-Vega R, Mbacham WF, Ali I, Nji A, Mousa A, Beshir KB, Chopo-Pizarro A, Kaur H, Okell L, Hansson H, Hocke EF, Alifrangis M, Gosling R, Roper C, Sutherland C, Chico RM.   +15 more
europepmc   +1 more source

Artesunate-amodiaquine efficacy in Congolese children with acute uncomplicated falciparum malaria in Brazzaville [PDF]

, 2013
Mathieu Ndounga, Pembé Issamou Mayengué, Prisca Nadine Casimiro, Dieudonné Loumouamou, Léonardo K. Basco, Francine Ntoumi, Philippe Brasseur   +6 more
openalex   +1 more source

Artemether-lumefantrine-amodiaquine or artesunate-amodiaquine combined with single low-dose primaquine to reduce Plasmodium falciparum malaria transmission in Ouélessébougou, Mali: a five-arm, phase 2, single-blind, randomised controlled trial.

Lancet Microbe
Mahamar A, Vanheer LN, Smit MJ, Sanogo K, Sinaba Y, Niambele SM, Diallo M, Dicko OM, Diarra RS, Maguiraga SO, Youssouf A, Sacko A, Keita S, Samake S, Dembele A, Teelen K, Dicko Y, Traore SF, Dondorp A, Drakeley C, Stone W, Dicko A.   +21 more
europepmc   +1 more source

Recent Advances in the Treatment of Malaria. [PDF]

Pharmaceutics
Alghamdi JM, Al-Qahtani AA, Alhamlan FS, Al-Qahtani AA.   +3 more
europepmc   +1 more source